GlassScriptPhysician profile
Matthew B Doppelt
NPI 1306891494
$36,214.90
in general payments reported to CMS, 2019-2025
38 companies · $2,757 in 2025
The $2,757 reported for 2025 was more than what 83% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $3,913 · 2021: $2,778 · 2022: $1,769 · 2023: $2,022 · 2024: $3,153 · 2025: $2,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,733 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,732.82 |
| Education | $199.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21,880.99 | 2019-2025 | Botox, Skyrizi, Rinvoq |
| Allergan, INC. | $2,536.28 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $1,897.42 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,322.54 | 2019-2025 | Nemluvio, Aklief |
| Janssen Biotech, INC. | $1,300.82 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $956.90 | 2020-2025 | Ilumya |
| Ucb, INC. | $683.78 | 2019-2025 | Bimzelx, Cimzia |
| E.R. Squibb & Sons, L.L.C. | $652.97 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $626.85 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Dermavant Sciences, INC. | $501.55 | 2023-2024 | Vtama |
| Genzyme Corporation | $495.97 | 2019-2025 | |
| Merz North America, INC. | $413.37 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $397.04 | 2023-2025 | Zoryve |
| Mayne Pharma Commercial LLC | $380.89 | 2019-2025 | |
| Pfizer INC. | $376.67 | 2019-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Doppelt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.